Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 05, 2020 16:30 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics Announces New Clinical and Preclinical Data for Rezafungin and Influenza AVCs from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

Abstract Book highlights new data from Cidara accepted for presentation at ECCMID 2020 Phase 2 trial shows superiority of rezafungin in time to clear deadly infection Seven abstracts highlight...
April 28, 2020 08:00 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics to Participate in Antifungal and COVID-19 Therapeutics Panels at Maxim Group’s Infectious Disease Virtual Conference

SAN DIEGO, April 28, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel...
April 07, 2020 08:00 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference

SAN DIEGO, April 07, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel...
March 04, 2020 05:55 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2019 Financial Results

SAN DIEGO, March 04, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel...
February 18, 2020 08:00 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics to Present at Transplantation & Cellular Therapy (TCT) and Mycology 2020 Medical Conferences

SAN DIEGO, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing therapeutics to improve the standard of care for patients facing severe...
February 12, 2020 17:30 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics Announces Closing of Rights Offering

SAN DIEGO, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (“Cidara”) today announced the closing of its previously announced rights offering (the “Rights Offering”). At...
January 22, 2020 07:55 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics Announces Commencement of Rights Offering

SAN DIEGO, Jan. 22, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (“Cidara”) today commenced the previously announced rights offering to raise gross proceeds of approximately...
January 10, 2020 08:00 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics Announces Proposed Rights Offering

Rights Offering will be available to all stockholders and 2018 warrant holders of record on January 21, 2020 $30.0 million to be raised, fully backstopped SAN DIEGO, Jan. 10, 2020 (GLOBE NEWSWIRE)...
December 03, 2019 08:00 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics to Present at Two Upcoming Medical Conferences

SAN DIEGO, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it...
November 18, 2019 08:00 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics Named a San Diego Metro Area Top Workplace for the Third Consecutive Year

SAN DIEGO, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it has...